Gunda I. Georg

Also affiliated with Innovative Design Labs (United States)

Arts and HumanitiesMedicineChemistryDecision SciencesSocial Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 18 papers. Top paper: “Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors”.

Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors

Molecular Cancer Therapeutics(2025)10.1158/1535-7163.mct-24-1053

N/A

0.165DataRank · unranked

2 citations

Alex T. Larsson, Bryant J. Keller, Katherine E. Chaney, Rory L. Williams, Minu Bhunia +8 more

BET proteins: Investigating BRDT as a potential target for male contraception

Bioorganic & Medicinal Chemistry Letters(2020)10.1016/j.bmcl.2020.126958

N/A

0DataRank · unranked

16 citations

Gunda I. Georg, Andrea Wisniewski

Review of rationale and progress toward targeting cyclin-dependent kinase 2 (CDK2) for male contraception†

Biology of Reproduction(2020)10.1093/biolre/ioaa107

N/A

0DataRank · unranked

27 citations

Nan Wang, Gunda I. Georg, Erik B. Faber

A special issue on contraceptive development: past, present, and future

Biology of Reproduction(2020)10.1093/biolre/ioaa120

N/A

0DataRank · unranked

7 citations

Gunda I. Georg, Wei Yan, Martin M. Matzuk

The Lonidamine Derivative H2-Gamendazole Reduces Cyst Formation in Polycystic Kidney Disease

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.09.09.258160

N/A

0DataRank · unranked

0 citations

Xia Zhou, Brenda S. Magenheimer, Gail A. Reif, Darren P. Wallace, Gunda I. Georg +6 more

Cytotoxicity of phenylpironetin analogs and the metabolic fate of pironetin and phenylpironetin

Bioorganic Chemistry(2022)10.1016/j.bioorg.2022.105915

N/A

0DataRank · unranked

5 citations

David S. Huang, Sara K. Coulup, Shameem Sultana Syeda, Henry Henry, L. Wong +2 more

Physiological Characterization of the Transporter-Mediated Uptake of the Reversible Male Contraceptive H2-Gamendazole Across the Blood-Testis Barrier

Journal of Pharmacology and Experimental Therapeutics(2022)10.1124/jpet.122.001195

N/A

0DataRank · unranked

7 citations

Joseph S. Tash, Gunda I. Georg, Stephen H. Wright, Nathan J. Cherrington, Raymond K. Hau

Development of allosteric, selective cyclin-dependent kinase 2 (CDK2) inhibitors that are negatively cooperative with cyclin binding and show potential as contraceptive agents

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.06.30.497818

N/A

0DataRank · unranked

4 citations

Jian Tang, Emily Roberts, Sornakala Ganeshkumar, Luxin Sun, Nan Wang +12 more

Development of allosteric and selective CDK2 inhibitors for contraception with negative cooperativity to cyclin binding

Nature Communications(2023)10.1038/s41467-023-38732-x

N/A

0DataRank · unranked

48 citations

Luxin Sun, Jian Tang, Emily Roberts, Sornakala Ganeshkumar, Nan Wang +13 more

Screening through Lead Optimization of High Affinity, Allosteric Cyclin-Dependent Kinase 2 (CDK2) Inhibitors as Male Contraceptives That Reduce Sperm Counts in Mice

Journal of Medicinal Chemistry(2023)10.1021/acs.jmedchem.2c01731

N/A

0DataRank · unranked

32 citations

Nan Wang, Kristen John, Luxin Sun, H.L.S. Wong, David J. Burban +12 more

Investigation of selective retinoic acid receptor alpha antagonist ER‐50891 and related analogs for male contraception

Archiv der Pharmazie(2023)10.1002/ardp.202300031

N/A

0DataRank · unranked

13 citations

Md Abdullah Al Noman, Rebecca A. D. Cuellar, Sanny S.W. Chung, Soma Maitra, Tahmina Naqvi +4 more

Strategies for developing retinoic acid receptor alpha-selective antagonists as novel agents for male contraception

European Journal of Medicinal Chemistry(2023)10.1016/j.ejmech.2023.115821

N/A

0DataRank · unranked

10 citations

Rebecca A. D. Cuellar, Jillian L. Kyzer, Sanny S.W. Chung, Narsihmulu Cheryala, Trinh A. D. Holth +8 more

Identification of TSSK1 and TSSK2 as Novel Targets for Male Contraception

Biomolecules(2025)10.3390/biom15040601

N/A

0DataRank · unranked

5 citations

Marıá Gracia Gervasi, Darya A. Tourzani, Yeva Shamailova, Hiroki Akizawa, S. Mohsen Taghavi +7 more

Strategies to Develop Na,K-ATPase-α4 Inhibitors as Male Contraceptives

International Journal of Molecular Sciences(2025)10.3390/ijms26125646

N/A

0DataRank · unranked

2 citations

Gladis Sánchez, Jeffrey P. McDermott, Narsihmulu Cheryala, H.L.S. Wong, Gunda I. Georg +2 more

Targeting cyclin-dependent kinase 2 (CDK2) interactions with cyclins and Speedy 1 (Spy1) for cancer and male contraception

Future Medicinal Chemistry(2025)10.1080/17568919.2025.2463868

N/A

0DataRank · unranked

3 citations

Kelsey A. Holdaway, Maryam Nazari, Laila Aiad, Bidisha Sarkar, Gunda I. Georg +1 more

Macrocyclic dihydropyridine analogs as pan-BET BD2-preferred inhibitors

European Journal of Medicinal Chemistry(2025)10.1016/j.ejmech.2025.117504

N/A

0DataRank · unranked

2 citations

Taimeng Liang, Jonathan Solberg, A. Chan, Prakriti Kalra, Rui Shi +5 more

Development of WEE2 kinase inhibitors as novel non-hormonal female contraceptives that target meiosis†

Biology of Reproduction(2020)10.1093/biolre/ioaa097

N/A

0DataRank · unranked

16 citations

Deepti Mudaliar, Kristen John, C. Leigh Allen, Luxin Sun, Jon E. Hawkinson +4 more

Progress towards a prodrug/enzyme intranasal delivery system for rapid prevention/reversal of seizure emergency

Journal of Controlled Release(2025)10.1016/j.jconrel.2025.114250

N/A

0DataRank · unranked

1 citations

Davin Rautiola, Narsihmulu Cheryala, Gunda I. Georg, James C. Cloyd, Ronald A. Siegel